The Liver Meeting 2026
Panel Hep Exchanges track
Top Questions in Alcohol-Associated Liver Disease: A Community Conversation on Glucagon-like Peptide-1 Receptor Agonists, Sex, and Integrated Care
Sat, Nov 7, 2026 · 3:45–4:45 PM MST Convention Center: Summit 3, The Park @TLM, Hall D, Colorado Convention Center
About this session
Alcohol-associated liver disease (ALD) is evolving faster than our clinical paradigms. Women are developing severe ALD at unprecedented rates despite lower alcohol consumption levels. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) offer tantalizing dual benefits for cravings and steatosis. Traditional screening tools may miss high-functioning patients with metabolic risk.
Speakers
-
Weill Cornell Medicine
Speaker
